Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
OtherClinical Investigations

18F-FDG PET in Detecting Metastatic Infectious Disease

Chantal P. Bleeker-Rovers, Fidel J. Vos, Geert J.A. Wanten, Jos W.M. van der Meer, Frans H.M. Corstens, Bart-Jan Kullberg and Wim J.G. Oyen
Journal of Nuclear Medicine December 2005, 46 (12) 2014-2019;
Chantal P. Bleeker-Rovers
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fidel J. Vos
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Geert J.A. Wanten
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jos W.M. van der Meer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frans H.M. Corstens
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bart-Jan Kullberg
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wim J.G. Oyen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • FIGURE 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1.

    (A) In 45-y-old woman with S. aureus septicemia and persistent fever during therapy, PET showed increased 18F-FDG uptake in multiple lesions in both lungs, mediastinum, and upper abdomen. Subsequently, chest CT also showed multiple lesions in both lungs and mediastinum. Cholangitis caused by gallstones was confirmed by abdominal ultrasound and endoscopic retrograde cholangiopancreatography (ERCP). Fever disappeared within 2 d after ERCP. (B) After 3 mo, 18F-FDG PET was normal and antibiotic therapy was discontinued.

Tables

  • Figures
    • View popup
    TABLE 1

    Characteristics of 40 Patients with Suspected Metastatic Infectious Disease on Whom 18F-FDG PET Was Performed

    CharacteristicTotal (n = 40)Metastatic foci
    Yes (n = 30)No (n = 10)
    Male (%)23 (58)17 (57)6 (60)
    Female (%)17 (42)13 (43)4 (40)
    Age (y)*60 ± 1760 ± 1760 ± 18
    Community-acquired infection (%)30 (75)23 (77)7 (70)
    Duration of symptoms until presentation (d)*†1 ± 81 ± 71 ± 9
    Duration of symptoms until adequate therapy (d)*†2 ± 83 ± 82 ± 9
    CVC present (%)13 (33)10 (33)3 (30)
    Duration of CVC present (wk)*12 ± 6214 ± 691 ± 9
    Total parenteral nutrition (%)9 (23)7 (23)2 (20)
    Diabetes mellitus (%)4 (10)3 (10)1 (10)
    Peritoneal dialysis (%)2 (5)1 (3)1 (10)
    Hemodialysis (%)1 (3)01 (10)
    Pacemaker (%)3 (8)3 (10)0
    Congenital heart disease (%)3 (8)3 (10)0
    Mechanical heart valve (%)2 (5)2 (7)0
    Malignancy (%)1 (3)1 (3)0
    Immunosuppressive drugs (%)8 (20)7 (23)1 (10)
    Intravenous drug use000
    Positive blood cultures (no. per patient)*3 ± 34 ± 3‡2 ± 1‡
    Duration of positive blood cultures (d)*2 ± 83 ± 8‡1 ± 1‡
    • ↵* Median ± SD.

    • ↵† One patient was excluded from these calculations because she had lower back pain, periodic low-grade fever, and fatigue for almost 3 y before she was diagnosed with a S. aureus psoas abscess and before 18F-FDG PET was performed.

    • ↵‡ P < 0.05.

    • View popup
    TABLE 2

    Culture Results

    CategoryTotal (n = 40)Metastatic foci
    Yes (n = 30)No (n = 10)
    Gram-positive bacteria
        Staphylococcus aureus1477
        Staphylococcus epidermidis110
        Streptococcus pneumoniae330
        Other Streptococcus spp.541
        Enterococcus spp.*211
    Gram-negative bacteria
        Escherichia coli330
        Proteus mirabilis110
        Enterobacter cloacae110
        Salmonella group D110
        Serratia marcescens110
    Yeasts
        Candida albicans660
        Candida parapsilosis211
        Candida tropicalis*101
    • ↵* In 1 patient, blood cultures were positive for Enterococcus faecium as well as Candida tropicalis.

    • View popup
    TABLE 3

    Portal of Entry: Source of Bacteremia or Fungemia

    DiagnosisTotal (n = 40)Metastatic foci
    Yes (n = 30)No (n = 10)
    CVC-related bloodstream infection1293
    Soft-tissue or skin infection514
    Pneumonia110
    Urinary tract infection440
    CAPD-peritonitis211
    Wound infection101
    Cholangitis211
    Meningitis110
    Unknown12120
    • CAPD = continuous ambulatory peritoneal dialysis.

    • View popup
    TABLE 4

    Localization of Metastatic Infectious Foci in 30 Patients Eventually Diagnosed with Metastatic Disease

    Organ systemPatients (n = 30)
    Endocarditis5
    Endovascular10
    Lungs7
    Liver or biliary tract2
    Spleen2
    Arthritis4
    Nonvertebral osteomyelitis1
    Vertebral osteomyelitis3
    Psoas abscess1
    Skin or soft tissue5
    Brain2
    Eye1
    • In 11 patients, metastatic infectious foci were found in >1 organ system.

    • View popup
    TABLE 5

    18F-FDG PET Results on 40 Patients with Suspected Metastatic Infectious Disease

    18F-FDG PET resultsPatients (n = 40)Confirmation
    TotalPartialNot
    Negative
        True-negative6
        False-negative0
    Positive
        True-positive31*2731
            Clinically relevant181521
            Clinically irrelevant1010
            Already known12*1200
        False-positive3003
    • ↵* In 1 patient with S. aureus bacteremia without metastatic infection, 18F-FDG uptake was seen in an abscess of his right arm, which was the source of his bacteremia. 18F-FDG PET was otherwise normal.

    • View popup
    TABLE 6

    Outcome of 40 Patients with Suspected Metastatic Infectious Disease

    CharacteristicTotal (n = 40)Metastatic foci
    Yes (n = 30)No (n = 10)
    Duration of fever (d)*18 ± 2725 ± 307 ± 14
    Duration of hospitalization (d)*45 ± 2547 ± 25†23 ± 18†
    Duration of antibiotic therapy (d)*50 ± 26675 ± 299†35 ± 16†
    Admission to ICU (%)7 (18)6 (20)1 (10)
    Duration of ICU stay (d)*2 ± 62 ± 62
    Cure (%)30 (75)20 (67)†10 (100)†
    Persistent infection (%)4 (10)4 (13)0
    Relapse (%)1 (3)1 (3)0
    Death (%)5 (13)5 (17)0
    • ↵* Median ± SD.

    • ↵† P < 0.05.

    • ICU = intensive care unit.

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 46 (12)
Journal of Nuclear Medicine
Vol. 46, Issue 12
December 1, 2005
  • Table of Contents
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
18F-FDG PET in Detecting Metastatic Infectious Disease
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
18F-FDG PET in Detecting Metastatic Infectious Disease
Chantal P. Bleeker-Rovers, Fidel J. Vos, Geert J.A. Wanten, Jos W.M. van der Meer, Frans H.M. Corstens, Bart-Jan Kullberg, Wim J.G. Oyen
Journal of Nuclear Medicine Dec 2005, 46 (12) 2014-2019;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
18F-FDG PET in Detecting Metastatic Infectious Disease
Chantal P. Bleeker-Rovers, Fidel J. Vos, Geert J.A. Wanten, Jos W.M. van der Meer, Frans H.M. Corstens, Bart-Jan Kullberg, Wim J.G. Oyen
Journal of Nuclear Medicine Dec 2005, 46 (12) 2014-2019;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • THIS MONTH IN JNM
  • PubMed
  • Google Scholar

Cited By...

  • 18F-FDG PET/CT-Guided Treatment Duration in Patients with High-Risk Staphylococcus Aureus Bacteremia: A Proof of Principle
  • Clinical Usefulness of 18F-FDG PET/CT for the Detection of Infections of Unknown Origin in Patients Undergoing Maintenance Hemodialysis
  • EANM/SNMMI Guideline for 18F-FDG Use in Inflammation and Infection
  • Cost-Effectiveness of Routine 18F-FDG PET/CT in High-Risk Patients with Gram-Positive Bacteremia
  • Nuclear Medicine Imaging of Infection in Cancer Patients (With Emphasis on FDG-PET)
  • Imaging of the Aortic Valve Using Fluorodeoxyglucose Positron Emission Tomography: Increased Valvular Fluorodeoxyglucose Uptake in Aortic Stenosis
  • 18F-FDG PET/CT for Detection of Metastatic Infection in Gram-Positive Bacteremia
  • Do Hyperglycemia and Diabetes Affect the Incidence of False-Negative 18F-FDG PET/CT Studies in Patients Evaluated for Infection or Inflammation and Cancer? A Comparative Analysis
  • 18F-FDG PET and PET/CT in Fever of Unknown Origin
  • Google Scholar

More in this TOC Section

  • Cardiac Presynaptic Sympathetic Nervous Function Evaluated by Cardiac PET in Patients with Chronotropic Incompetence Without Heart Failure
  • Validation and Evaluation of a Vendor-Provided Head Motion Correction Algorithm on the uMI Panorama PET/CT System
  • Left Ventricular Strain from Myocardial Perfusion PET Imaging: Method Development and Comparison to 2-Dimensional Echocardiography
Show more Clinical Investigations

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire